Related Experiment Video
Updated: Oct 2, 2025
09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.6K
Seizure activity triggers tau hyperphosphorylation and amyloidogenic pathways
Geoffrey Canet1,2, Emma Zub2, Charleine Zussy1
1Molecular Mechanisms in Neurodegenerative Dementia Laboratory, University of Montpellier, EPHE-PSL, INSERM U1198, Montpellier, France.
Epilepsia
|February 28, 2022
Summary
Experimental seizures can trigger tau hyperphosphorylation and amyloidogenic changes in the brain, linking epilepsy to Alzheimer's disease pathways and neuroinflammation over time.
Area of Science:
- Neuroscience
- Pathology
- Molecular Biology
Background:
- Epilepsies and neurodegenerative disorders share similarities, but direct links are unclear.
- Investigating the impact of seizures on neurodegenerative processes is crucial.
Purpose of the Study:
- To test if experimental seizures induce tau hyperphosphorylation and amyloidogenic modifications.
- To examine the role of neuroinflammation in these processes.
Main Methods:
- Used kainic acid (KA) models for mesial temporal lobe epilepsy (MTLE) and generalized status epilepticus (SE) in mice.
- Analyzed tau phosphorylation, amyloidogenic pathways, and glial inflammation at 72 hours, 1 week, and 8 weeks post-injection.
Main Results:
- MTLE induced long-lasting tau hyperphosphorylation and amyloidogenic markers in the hippocampus, correlating with neuroinflammation.
- These changes extended to seizure-propagating zones without lesions.
- Generalized SE caused transient changes, while MTLE showed persistent alterations, overlapping with Alzheimer's disease models.
Conclusions:
- Epilepsy, particularly MTLE, can initiate Alzheimer's disease-relevant molecular changes.
- These changes involve tau pathology and amyloidogenic pathways, intertwined with persistent neuroinflammation.
- The findings highlight a molecular trajectory from seizures to neurodegeneration.
Related Concept Videos
03:03Amyloid Fibrils
10.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
10.3K
01:26Alzheimer's Disease: Overview
712
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
712
01:00Enzyme-linked Receptors
80.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.4K
01:24Epilepsy and Seizures: Overview
321
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
321